Marchex (MCHX) Research & Development (2010 - 2025)

Marchex (MCHX) has 16 years of Research & Development data on file, last reported at $2.2 million in Q4 2025.

• Research & Development for Q4 2025 came in at $2.2 million, down 22.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.7 million (down 21.49% YoY), and the FY2025 annual result was $9.7 million, down 21.48% from the prior year.
• Research & Development eased to $2.2 million in Q4 2025 per MCHX's latest filing, from $2.4 million in the prior quarter.
• Over five years, Research & Development peaked at $5.3 million in Q1 2021 and troughed at $2.2 million in Q4 2025.
• A 5-year average of $3.4 million and a median of $3.2 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2021 and 2022: Research & Development slumped 45.39% in 2021, then soared 36.03% in 2022.
• A 5-year view of Research & Development shows it stood at $2.8 million in 2021, then soared by 36.03% to $3.8 million in 2022, then dropped by 17.89% to $3.2 million in 2023, then slipped by 9.9% to $2.8 million in 2024, then decreased by 22.39% to $2.2 million in 2025.
• Business Quant data shows MCHX's Research & Development at $2.2 million in Q4 2025, $2.4 million in Q3 2025, and $2.5 million in Q2 2025.